Skip to main content

Immucell Value Stock - Dividend - Research Selection

Immucell

ISIN: US4525253062, WKN: 885825

Market price date: 28.05.2021
Market price: 9,77 USD




Immucell Fundamental data and company key figures of the share

Annual reports in USD
Key figures 01-04-2021
Cash flow
Net operating cash flow 1.315.580
Capital Expenditures -4.072.540
Free cash flow -2.756.960
Balance sheet
Total Equity 28.266.200
Liabilities & Shareholders equity 40.349.600
Income statement
Net income -1.022.120
Eps (diluted) -0,140
Diluted shares outstanding 7.213.330
Net sales/revenue 15.342.000

Fundamental ratios calculated on: 28-05-2021

Ratios
Key figures 28-05-2021
Cash flow
P/C 53,57
   
P/FC -25,56
Balance sheet
ROI-2,53
ROE70,05
Income statement
P/E-69,79
Div. Yield0,00%
P/B2,49
P/S4,59


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolICCC
Market Capitalization70.474.232,00 USD
Country
IndicesNASDAQ Comp.
Sectors
Raw Data SourceUS GAAP in Millionen USD
Stock Split1990-07-26,1.0000/100.0000; 1990-07-25,1.0000/100.0000; 1990-07-24,1.000000/100.000000
Internetwww.immucell.com


Description of the company

ImmuCell Corporation creates scientifically proven and practical products that result in a measurable economic impact on animal health and productivity in the dairy and beef industries. The Company´s product, First Defense, is manufactured from cows´ colostrum using the Company´s vaccine and whey protein purification technologies. The target disease, bovine enteritis (calf scours), causes diarrhea and dehydration in newborn calves and often leads to serious sickness and even death. First Defense is the only USDA-licensed, orally delivered scours preventive product on the market for calves with claims against E. coli K99 and coronavirus (two causes of scours). First Defense provides bovine antibodies that newborn calves need. Wipe Out Dairy Wipes consist of biodegradable towelettes that are pre-moistened with a Nisin to prepare the teat area of a cow in advance of milking.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.immucell.com